Does BREXUCABTAGENE AUTOLEUCEL Cause Disease progression? 93 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 93 reports of Disease progression have been filed in association with BREXUCABTAGENE AUTOLEUCEL (TECARTUS). This represents 5.3% of all adverse event reports for BREXUCABTAGENE AUTOLEUCEL.
93
Reports of Disease progression with BREXUCABTAGENE AUTOLEUCEL
5.3%
of all BREXUCABTAGENE AUTOLEUCEL reports
44
Deaths
13
Hospitalizations
How Dangerous Is Disease progression From BREXUCABTAGENE AUTOLEUCEL?
Of the 93 reports, 44 (47.3%) resulted in death, 13 (14.0%) required hospitalization, and 4 (4.3%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BREXUCABTAGENE AUTOLEUCEL. However, 93 reports have been filed with the FAERS database.
What Other Side Effects Does BREXUCABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (827)
Immune effector cell-associated neurotoxicity syndrome (529)
Neurotoxicity (192)
Death (153)
Pyrexia (119)
Hypotension (109)
Fatigue (86)
Febrile neutropenia (69)
Confusional state (63)
Encephalopathy (53)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which BREXUCABTAGENE AUTOLEUCEL Alternatives Have Lower Disease progression Risk?
BREXUCABTAGENE AUTOLEUCEL vs BRIGATINIB
BREXUCABTAGENE AUTOLEUCEL vs BRILINTA
BREXUCABTAGENE AUTOLEUCEL vs BRILIQUE
BREXUCABTAGENE AUTOLEUCEL vs BRIMONIDINE
BREXUCABTAGENE AUTOLEUCEL vs BRIMONIDINE\BRINZOLAMIDE